Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATCAR: Pre-hospital Thrombolytic Therapy With Urgent Revascularization
NCT00178620Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Sep 2003
- Primary completion
- Dec 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of reteplase in acute myocardial infarction (AMI) (4 arms), sponsored by UTHealth Houston. Primary endpoint: Mortality at 30 Days. Started Sep 2003; status: completed.
02
Drugs
reteplase
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00178620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178620.